Khaitan & Co acts on NATCO Pharma ₹1,279 crore rights issue
NATCO Pharma Limited has made a rights issue of 17,058,082 fully paid-up equity shares, aggregating to ₹1,279.4 crore. Khaitan & Co advised NATCO Pharma on this rights issue. The transaction team consisted of Thomas George (Partner), Nagashayana Srinivasaiah (Partner), Pooja Agarwal (Senior Associate), Tharun Vadlapatla (Senior Associate), Anand Sivasankaran (Associate) and Shishir Tripathi (Associate).
Sources
Open in the live tracker →Related deals
- AZB & Partners, S&R Associates, Hogan Lovells Cadwalader acts on Paras Hospitals ₹1,450 crore IPO31 Oct 2026 · ₹1,450 cr
- Khaitan & Co advises as BKT Tyres wheels in Pirelli to India31 Oct 2026
- Khaitan, Latham, SAM, Linklaters act on Persistent Systems ₹4,264 crore QIP30 Oct 2026 · ₹4,264 cr
- Paras Healthcare Limited: Updates30 Oct 2026
- Sudarshan Pharma Industries Limited: Issue of Securities30 Oct 2026 · ₹72 cr
- Khaitan & Co, Metalegal act on L'Oreal acquiring majority stake in Innovist29 Oct 2026